Zobrazeno 1 - 10
of 203
pro vyhledávání: ''
Publikováno v:
Ophthalmology Retina. 6:213-218
Purpose To calculate costs required to prevent center-involved diabetic macular edema (CI-DME) or proliferative diabetic retinopathy (PDR), and to improve the diabetic retinopathy severity score (DRSS) with intravitreal anti-VEGF injections as report
Autor:
Jong Pascal Hendrik Pieter de, Hazes Johanna Maria Wilhelmina, Mulligen van Elise, Luurssen-Masurel Nathalie, Weel Angelique Elisabeth Adriana Maria
Publikováno v:
Rheumatology (Oxford, England)
Rheumatology (United Kingdom), 60(12), 5765-5774. Oxford University Press
Rheumatology (United Kingdom), 60(12), 5765-5774. Oxford University Press
Objectives To evaluate the 1-year cost-effectiveness between three different initial treatment strategies in autoantibody-negative RA patients, according to 2010 criteria. Methods For this analysis we selected all RA patients within the intermediate
Publikováno v:
Clinical Drug Investigation
Background Sacubitril-valsartan is effective in reducing the N-terminal pro-B-type natriuretic peptide level of hospitalized patients with acute decompensated heart failure, with a high acquisition cost compared with enalapril treatment. Objective Th
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Scientific Reports
Scientific Reports
BackgroundDue to COVID-19’s significant morbidity and mortality, identifying the most cost-effective pharmacologic treatment strategy is critical. As such, we determined the most cost-effective strategy for moderate to severe COVID-19 respiratory i
Publikováno v:
International Forum of Allergy & Rhinology. 11:1626-1636
Background Chronic rhinosinusitis with nasal polyposis (CRSwNP) in the setting of aspirin-exacerbated respiratory disease (AERD) is a disease that is difficult to treat and prone to recurrence. Dupilumab is a promising treatment for these patients, b
Autor:
Juan Manuel Ramos-Goñi, Daniela Ortín-Sulbarán, Mark Oppe, Carlos Vila Silván, Anabel Estévez-Carrillo
Publikováno v:
The European Journal of Health Economics
Background Uncertainty in model-based cost-utility analyses is commonly assessed in a probabilistic sensitivity analysis. Model parameters are implemented as distributions and values are sampled from these distributions in a Monte Carlo simulation. B
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 21:489-495
This study aimed to estimate the cost-utility of stereotactic body radiotherapy (SBRT) plus cetuximab for patients with previously irradiated recurrent squamous cell carcinoma of the head and neck.We constructed a Markov health-state transition model
Autor:
Damian Mullan, Rachel Evans, Paul Ross, Noemi Muszbek, Victoria K Brennan, Edit Remak, Fabien Colaone, Suki Shergill
Publikováno v:
Future Oncology. 17:1055-1068
Background: The study assessed the cost-utility of selective internal radiation therapy (SIRT) with Y-90 resin microspheres versus sorafenib in UK patients with unresectable hepatocellular carcinoma ineligible for transarterial chemoembolization. Mat
Autor:
M. Michel, E. Le Page, D.A. Laplaud, R. Wardi, C. Lebrun, F. Zagnoli, S. Wiertlewski, M. Coustans, G. Edan, K. Chevreul, D. Veillard, F. Lallement, M. Cohen, C. Blanchard, E. Sartori, O. Demarco, F. Rouhart, C. Papeix, G. Taurin, T. Anani, P. Kassiotis, C. Hamon, M.A. Lester, M. Merienne
Publikováno v:
Revue Neurologique
Revue Neurologique, 2022, 178 (3), pp.241-248. ⟨10.1016/j.neurol.2021.06.009⟩
Revue Neurologique, Elsevier Masson, 2021, ⟨10.1016/j.neurol.2021.06.009⟩
Revue Neurologique, 2022, 178 (3), pp.241-248. ⟨10.1016/j.neurol.2021.06.009⟩
Revue Neurologique, Elsevier Masson, 2021, ⟨10.1016/j.neurol.2021.06.009⟩
International audience; Background: Studies have shown that oral high-dose methylprednisolone (MP) is non-inferior to intravenous MP in treating multiple sclerosis relapses in terms of effectiveness and tolerance. In order to assist with resource all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e5e81c07d2510bf92993c34f99a5caa
https://univ-rennes.hal.science/hal-03414558
https://univ-rennes.hal.science/hal-03414558
Autor:
Meghna Jani, Timothy J. McDonald, Segun Bello, Andriy Kharechko, Huiqin Yang, Irina A Tikhonova, Andrew Salmon, Sophie Robinson, Martin Hoyle, Sophie Dodman, Richard C Haigh, Mohsen Rezaei Hemami
Publikováno v:
Health Technol Assess
Tikhonova, I A, Yang, H, Bello, S, Salmon, A, Robinson, S, Hemami, M R, Dodman, S, Kharechko, A, Haigh, R C, Jani, M, Mcdonald, T J & Hoyle, M 2021, ' Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis : a systematic review and economic evaluation ', Health Technology Assessment, vol. 25, no. 8, pp. 1-248 . https://doi.org/10.3310/hta25080
Health Technology Assessment, Vol 25, Iss 8 (2021)
Tikhonova, I A, Yang, H, Bello, S, Salmon, A, Robinson, S, Hemami, M R, Dodman, S, Kharechko, A, Haigh, R C, Jani, M, Mcdonald, T J & Hoyle, M 2021, ' Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis : a systematic review and economic evaluation ', Health Technology Assessment, vol. 25, no. 8, pp. 1-248 . https://doi.org/10.3310/hta25080
Health Technology Assessment, Vol 25, Iss 8 (2021)
Background Rheumatoid arthritis is a chronic autoimmune disease that primarily causes inflammation, pain and stiffness in the joints. People with severe disease may be treated with biological disease-modifying anti-rheumatic drugs, including tumour n